학술논문

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Document Type
Erratum
Source
Alzheimer's Research & Therapy. 15(1)
Subject
Language
English
ISSN
1758-9193